EUVIMEDDécouvrir EUVIMED
Open access · CC BY 4.0

Retroperitoneal lymph‐node dissection for isolated nodal recurrence of renal cell carcinoma after nephrectomy: Contemporary outcomes of a case series

Alberto Costa Silva iD, Noel Clarke, Aziz Gulamhusein

BJUI Compass · 2026-07 · 7 (7)

DOI: 10.1002/bco2.70190 ↗

At a glance

Journal article in BJUI Compass, published online on 2026-06-29. Written by Alberto Costa Silva and 2 co-authors. Institution: The Christie NHS Foundation Trust Manchester UK. 12 references. The full text is freely available (open access, CC BY 4.0).

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Background and objective Isolated retroperitoneal lymph‐node (RPLN) recurrence after radical nephrectomy (RN) for renal cell carcinoma (RCC) is uncommon, and optimal management remains undefined. This study reports contemporary outcomes of retroperitoneal lymph‐node dissection (RPLND) for isolated nodal recurrence, including in patients previously treated with stereotactic ablative body radiotherapy (SABR) or systemic therapy.

Methods

A retrospective review was performed of all patients undergoing RPLND for isolated nodal recurrence of RCC between July 2023 and October 2024. Clinical, operative, and pathologic variables were collected, and postoperative complications were graded using the Clavien–Dindo system. Recurrence‐free survival (RFS) was calculated from RPLND to recurrence or last follow‐up.

Results

Eight patients met inclusion criteria. Median age at RPLND was 59.5 years, and six were male. The median interval from RN to RPLND was 29 months. Median operative time was 255 min, estimated blood loss 300 mL, and hospital stay 6.5 days. One patient experienced postoperative complication (Clavien–Dindo IIIa). All specimens confirmed malignancy with negative margins. After a median follow‐up of 18 months, three patients (37.5%) recurred, with a mean RFS of 15.3 months.

Conclusions

RPLND is a safe and viable option for isolated nodal recurrence of RCC, offering complete resection and oncologic outcomes comparable to historical data, and may serve as an important component of multimodal management.

Subjects

Author keywords

lymph node recurrencerenal cell carcinomaretroperitoneal lymph‐node dissection

Authors and institutions

  • The Christie NHS Foundation Trust Manchester UK.
  • Faculty of Medicine of University of Porto, RISE-Health Research Network University Hospital Centre of São João Porto Portugal.

ORCID profiles: Alberto Costa Silva

Cite

APA

Costa Silva, A., Clarke, N., & Gulamhusein, A. (2026). Retroperitoneal lymph‐node dissection for isolated nodal recurrence of renal cell carcinoma after nephrectomy: Contemporary outcomes of a case series. BJUI Compass, 7(7). https://doi.org/10.1002/bco2.70190

Vancouver

Costa Silva A, Clarke N, Gulamhusein A. Retroperitoneal lymph‐node dissection for isolated nodal recurrence of renal cell carcinoma after nephrectomy: Contemporary outcomes of a case series. BJUI Compass. 2026;7(7). doi:10.1002/bco2.70190

BibTeX
@article{CostaSilva2026,
  author = {Costa Silva, Alberto and Clarke, Noel and Gulamhusein, Aziz},
  title = {Retroperitoneal lymph‐node dissection for isolated nodal recurrence of renal cell carcinoma after nephrectomy: Contemporary outcomes of a case series},
  journal = {BJUI Compass},
  year = {2026},
  volume = {7},
  number = {7},
  doi = {10.1002/bco2.70190}
}
Start for free →